Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Weekly shot may replace daily growth hormone for turner syndrome kids

NCT ID NCT05690386

First seen Jan 12, 2026 · Last updated May 20, 2026 · Updated 16 times

Summary

This study tests if a once-weekly injection of lonapegsomatropin works as well as daily somatropin to help children with Turner syndrome grow taller. About 48 children aged 1 to 10 who have not had growth hormone before will take part. The goal is to see if the weekly shot is safe and effective over 2 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TURNER SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ascendis Pharma Investigational Site

    Palo Alto, California, 94304, United States

  • Ascendis Pharma Investigational Site

    San Diego, California, 92123, United States

  • Ascendis Pharma Investigational Site

    Aurora, Colorado, 80045, United States

  • Ascendis Pharma Investigational Site

    Orlando, Florida, 32827, United States

  • Ascendis Pharma Investigational Site

    St. Petersburg, Florida, 33701-4804, United States

  • Ascendis Pharma Investigational Site

    Atlanta, Georgia, 30322, United States

  • Ascendis Pharma Investigational Site

    Idaho Falls, Idaho, 83404, United States

  • Ascendis Pharma Investigational Site

    Chicago, Illinois, 60611, United States

  • Ascendis Pharma Investigational Site

    Boston, Massachusetts, 02114, United States

  • Ascendis Pharma Investigational Site

    Saint Paul, Minnesota, 55102, United States

  • Ascendis Pharma Investigational Site

    Las Vegas, Nevada, 89113, United States

  • Ascendis Pharma Investigational Site

    Lake Success, New York, 11042, United States

  • Ascendis Pharma Investigational Site

    Chapel Hill, North Carolina, 27599, United States

  • Ascendis Pharma Investigational Site

    Cincinnati, Ohio, 45229, United States

  • Ascendis Pharma Investigational Site

    Oklahoma City, Oklahoma, 73104, United States

  • Ascendis Pharma Investigational Site

    Portland, Oregon, 97239, United States

  • Ascendis Pharma Investigational Site

    El Paso, Texas, 79902, United States

  • Ascendis Pharma Investigational Site

    Fort Worth, Texas, 76104, United States

  • Ascendis Pharma Investigational Site

    Seattle, Washington, 98105, United States

Conditions

Explore the condition pages connected to this study.